AHR and kidney disorder: Minority monogenic and majority monogenic GKDs were associated with reduced 10-year mortality risk in kidney transplant recipients on multivariable analyses (majority monogenic AHR 0.82, 95% CI 0.71–0.93; minority monogenic AHR 0.80, 95% 0.68–0.95; Table 4, Supplementary Table S3).Graft failure-censored mortality was reduced in transplant recipients with majority monogenic GKD compared to other kidney diseases (AHR 0.84, 95% CI 0.76–0.93, Supplementary Table S4).